| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35231-10ug | |||
| Carrier-Free | NBP2-35231-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50289-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12037-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52696-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75194-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11965-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34950-10ug | |||
| Carrier-Free | NBP2-34950-1mg | |||
| Carrier-Free | NBP2-34950-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81031-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52643-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75198-0.025mg | |||
![Western Blot: SH2D1A Antibody [NBP3-30818] - Western blot analysis using SAP antibody on NK-92 cell lysate at 10ug/ml).](http://images.novusbio.com/fullsize/nbp3-30818_rabbit-sh2d1a-pab-811202420592177.jpg "Western Blot: SH2D1A Antibody [NBP3-30818] - Western blot analysis using SAP antibody on NK-92 cell lysate at 10ug/ml).")
![Flow Cytometry: CD3 Antibody (MM1A) [NBP2-60876] - Obtained with bovine leukocytes](http://images.novusbio.com/fullsize/CD3-Antibody-MM1A-Flow-Cytometry-NBP2-60876-img0001.jpg "Flow Cytometry: CD3 Antibody (MM1A) [NBP2-60876] - Obtained with bovine leukocytes")
![SDS-Page: Porcine IL-2 Protein [NBP2-35231]](http://images.novusbio.com/fullsize/Porcine-IL-2-Protein-SDS-Page-NBP2-35231-img0001.jpg "SDS-Page: Porcine IL-2 Protein [NBP2-35231]")
![ELISA: CD96 Antibody (6A6) - Chimeric [NBP3-12037] - Binding curve of the rabbit chimeric version of the anti-CD96 antibody 6A6 (blue line) to an ELISA plate coated with mouse CD96-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10000 to 1.7 ng/ml was performed using NBP3-12037. For signal detection, a 1:4000 dilution of anti-rabbit IgG1 HRP antibody was used.](http://images.novusbio.com/fullsize/CD96-Antibody-6A6-Chimeric-ELISA-NBP3-12037-img0001.jpg "ELISA: CD96 Antibody (6A6) - Chimeric [NBP3-12037] - Binding curve of the rabbit chimeric version of the anti-CD96 antibody 6A6 (blue line) to an ELISA plate coated with mouse CD96-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10000 to 1.7 ng/ml was performed using NBP3-12037. For signal detection, a 1:4000 dilution of anti-rabbit IgG1 HRP antibody was used.")
![SDS-Page: Equine IL-2 Protein [NBP2-34950]](http://images.novusbio.com/fullsize/Equine-IL-2-Protein-SDS-Page-NBP2-34950-img0001.jpg "SDS-Page: Equine IL-2 Protein [NBP2-34950]")
![Immunocytochemistry/Immunofluorescence: CD3 epsilon Antibody (OKT-3 (muromonab)) [NBP2-81031] - Immunofluorescence staining of fixed Molt4 cells with CD3 epsilon Antibody (OKT-3 (muromonab)) [NBP2-81031]. Immunofluorescence analysis of paraformaldehyde fixed Molt4 cells on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of OKT-3 [NBP2-81031] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81031, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-OKT-3-muromonab-Immunocytochemistry-Immunofluorescence-NBP2-81031-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD3 epsilon Antibody (OKT-3 (muromonab)) [NBP2-81031] - Immunofluorescence staining of fixed Molt4 cells with CD3 epsilon Antibody (OKT-3 (muromonab)) [NBP2-81031]. Immunofluorescence analysis of paraformaldehyde fixed Molt4 cells on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of OKT-3 [NBP2-81031] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81031, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.")
![Flow Cytometry: CD3 epsilon Antibody (500A2) - Chimeric [NBP2-52643] - Mouse lymphocytes were stained with an anti-CD44 control (panel A) or the rabbit-chimeric version of 500A2 (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-500A2-Chimeric-Flow-Cytometry-NBP2-52643-img0002.jpg "Flow Cytometry: CD3 epsilon Antibody (500A2) - Chimeric [NBP2-52643] - Mouse lymphocytes were stained with an anti-CD44 control (panel A) or the rabbit-chimeric version of 500A2 (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![ELISA: CD27/TNFRSF7 Antibody (RM27-3E5) - Chimeric - Azide and BSA Free [NBP2-75198] - Binding curves of NBP2-75198 (red line) and isotype control (anti-Fluorescein antibody; blue line) to an ELISA plate coated with CD27-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10 mg/mL to 0.17 ng/ml of NBP2-75198 was used. CD70 (CD27-L) is the ligand for CD27. CD70 Fc-fusion protein was added to a 10mg/mL solution of NBP2-75198 starting at 10mg/mL, and then at 3-fold dilutions down to 0.17ng/mL (red line). A negative control assay using 4-1BB Fc-fusion protein was also performed (yellow line). For signal detection, a 1:4000 dilution of HRP-labelled anti-human IgG antibody was used.](http://images.novusbio.com/fullsize/nbp2-75198_rabbit-monoclonal-cd27-tnfrsf7-antibody-rm27-3e5-chimeric-7420252228563.png "ELISA: CD27/TNFRSF7 Antibody (RM27-3E5) - Chimeric - Azide and BSA Free [NBP2-75198] - Binding curves of NBP2-75198 (red line) and isotype control (anti-Fluorescein antibody; blue line) to an ELISA plate coated with CD27-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10 mg/mL to 0.17 ng/ml of NBP2-75198 was used. CD70 (CD27-L) is the ligand for CD27. CD70 Fc-fusion protein was added to a 10mg/mL solution of NBP2-75198 starting at 10mg/mL, and then at 3-fold dilutions down to 0.17ng/mL (red line). A negative control assay using 4-1BB Fc-fusion protein was also performed (yellow line). For signal detection, a 1:4000 dilution of HRP-labelled anti-human IgG antibody was used.")